Login

Biotech company picks suburban Raleigh for $700 million East Coast manufacturing plant

Genentech's 700,000-square-foot facility marks latest major pharma project planned in Holly Springs
Genentech operates a large corporate campus in South San Francisco. (CoStar)
Genentech operates a large corporate campus in South San Francisco. (CoStar)
CoStar Analytics
May 14, 2025 | 4:18 P.M.

A California-based pharmaceutical company has picked Holly Springs, North Carolina, for the site of its first drug manufacturing plant on the East Coast, the latest in a string of recent life science industry announcements that have spurred a building boom in the small Raleigh suburb.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE


  • Properties